Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ChiRhoClin is a specialty pharmaceutical company focused on the development and commercialization of orphan drug products for the gastrointestinal and pancreatic markets. The company is best known for its development of ChiRhoStim (human secretin), a diagnostic agent used in pancreatic function testing and the identification of gastrinoma. Founded in 1996, ChiRhoClin operates as a family-owned business dedicated to providing essential diagnostic tools for rare diseases that are often overlooked by larger pharmaceutical firms. Their primary mission involves ensuring the availability of secretin for clinical and research applications in gastroenterology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ChiRho Pharmaceuticals.